Skip to main content
. 2024 Jun 14;5(8):101003. doi: 10.1016/j.patter.2024.101003

Table 1.

Harmonized variables and domains in DRPP

Domain Variables Units/categories Label
Demographic age years age of participant at that visit
Demographic education no school/grade school; high school; technical/vocational/college/graduate/professional educational categories
Demographic gender female; male gender
Demographic race_ethnicity White; Black; Hispanic; Asian; other race/ethnicity of participant
Clinical risk factors A1C % hemoglobin A1C
Clinical risk factors BMI kg/m2 body mass index
Clinical risk factors casual_plasma_glucose mg/dL plasma glucose taken when patient has not fasted
Clinical risk factors diastolic_blood_pressure mmHg average of diastolic blood pressure; used right arm when the choice was presented
Clinical risk factors fasting_plasma_glucose mg/dL fasting plasma glucose
Clinical risk factors HDL_cholesterol mg/dL high-density lipoprotein cholesterol
Clinical risk factors height cm height (cm)
Clinical risk factors LDL_cholesterol mg/dL low-density lipoprotein cholesterol
Clinical risk factors systolic_blood_pressure mmHg average of systolic blood pressure; used right arm when the choice was presented
Clinical risk factors total_cholesterol mg/dL total cholesterol
Clinical risk factors use_of_anti_diabetic_medication yes; no use of anti-diabetic medication at current visit
Clinical risk factors use_of_anti_hypertensive_medication yes; no use of anti-hypertensive medication at current visit
Clinical risk factors use_of_lipid_lowering_medication yes; no use of lipid-lowering medication at current visit
Clinical risk factors weight kg weight (kg)
Lifestyle pa_met_per_week metabolic equivalent of task (MET) (min/week) moderate and vigorous physical activity
Outcomes cesd_score Center for Epidemiological Studies-Depression (CESD)
Outcomes chd yes; no coronary heart disease (CHD); includes heart failure and/or heart attack
Outcomes chd_followup days days to CHD event, death, or end of follow-up
Outcomes cvd yes; no cardiovascular disease (CVD); includes CHD and/or stroke
Outcomes cvd_followup days days to CVD event, death, or end of follow-up
Outcomes death yes; no death indicator
Outcomes death_followup days days to death or end of follow-up
Outcomes dementia yes; no dementia indicator
Outcomes dementia_followup days intermediate variables used to calculate dementia follow-up
Outcomes depression_assess yes; no indicator of depression; based on CESD or Geriatric Depression Scale (GDS)
Outcomes gds_score Geriatric Depression Scale
Outcomes stroke yes; no stroke indicator
Outcomes stroke_followup days days to stroke event, death, or end of follow-up
Chronic diseases diabetes normal; pre-diabetes; diabetes diabetes definition based on fasting plasma glucose, random casual glucose, A1C, and use of anti-diabetic medication
Chronic diseases hypercholesterolemia normal; elevated; hypercholesterolemia hypercholesterolemia definition based on use of lipid-lowering medication and total cholesterol
Chronic diseases hypertension normal BP; elevated BP; hypertension stage 1; hypertension stage 2 hypertension definition based on use of anti-hypertensive medication and blood pressure
Genetic APOE 34/44; 33; 22/23; 24 APOE allele carrier
Dates denom yes indicator of participant being in denominator for that visit
Dates cal_time days days from 1960-01-01 to current visit
Dates days_to_visit days days from initial visit to current visit
Cognitive tests mmse cognitive tests; mini-mental state examination
Behavioral AHA_Score 0; 1; 2 American Heart Association diet score; 0 = poor; 1 = intermediate; 2 = ideal
Behavioral alcohol g/week alcohol consumption in grams/week
Behavioral smoking non-smoker; former smoker; current smoker smoking status

The psHarmonize package was used by the research team to harmonize data from multiple cohorts. This table lists the 43 variables that were harmonized.